Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia

Journal of Chemotherapy

Volumn 17, Issue 4, 2005, Pages 367-375

  Bedenić, Branka ^a   Schmidt, H ^b   Herold, S ^c   Monaco, M ^d   Plecko V ^e   Kalenic S ^e   Katic S ^e   Skrlin Subic J ^f  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e KBC Zagreb   (Croatia)

^f University of Zagreb School of Medicine   (Croatia)

Author keywords

Aztreonam; Ceftazidime; Klebsiella pneumoniae; Plasmids; SHV 5 lactamase

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEPHALOSPORIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CROATIA; DILUTION; ENDEMIC DISEASE; EPIDEMIC; GENE SEQUENCE; HOSPITAL; HOSPITAL HYGIENE; HOSPITAL INFECTION; HYDROLYSIS; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION;

EID: 24744431596     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.4.367     Document Type: Article

References (32)

1. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33(8): 1131-6.
2. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35(9): 1697-1704.
3. Bedenić B, Žagar Ž. Extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia. J Chemother 1998; 10(6): 449-59.
4. Bedenić B, Randegger CC, Stobberingh E, Haechler H. Molecular epidemiology of extended-spectrum β-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia. Eur J Clin Microbiol Infect Dis 2001; 20(7): 505-8.
5. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard. NCCLS document M100-S9, Vol. 19, No 1. Villanova, PA: NCCLS, 1999.
6. National Committee for Clinical Laboratory standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard. 5th ed. NCCLS document M7-A5, Wayne, Pennsylvania: NCCLS, 2000: 1-25.
7. nd ed. Baltimore MD: Williams & Wilkins, 1986: 683-721.
8. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10(4): 867-78.
9. Matthew MA, Harris AM, Marshall MJ, Ross GW. The use of isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975; 88: 169-178.
10. Labia R, Guionie M: Semi-quantification of a microbiological method using β-lactamases in detecting the hydrolysis of β-lactam antibiotics. Ann Microbiol 1981; 132B(2): 257-65.
11. Nüesch-Inderbinen MT, Hächler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996; 15(5): 398-402.
12. Hall TA. Bio Edit: a user-friendly biological for sequence alignments and analysis program for Windows 95/98 NT. Nucleic Acids Symp Ser 2004; 41: 95-8.
13. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic acid research 1979; 7(6): 1513-23.
14. Kaufman ME. Pulsed-Field Gel Electrophoresis. In: Woodfor N, Johnsons A, eds. Molecular bacteriology. Protocols and clinical applications. New York; Humana Press Inc. Totowa, 1998: 33-51.
15. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-filed gel electrophoresis; criteria for bacterial strain typing. J Clin Microbiol 1995; 33(9): 2233-9.
16. Bauernfeind A, Rosenthal E, Eberlein E, Holley M, Schweighart S. Spread of Klebsiella pneumoniae producing SHV-5 β-lactamase among hospitalized patients. Infection 1993; 21(1): 18-22.
17. Prodinger WM, Fille M, Bauernfeind A, et al. Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34(3): 564-8.
18. Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5 type extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42(3): 514-520.
19. Marchese A, Arlet G, Schito GC, Langrange PH, Philippon A. Detection of SHV-5 β-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis 1996; 15(3): 245-8.
20. Gutmann L, Ferre B, Goldstein FW, et al. SHV-5 a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989; 33(6): 951-6.
21. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β- lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996; 34(2): 358-63.
22. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26(5): 635-48.
23. Pragai Z, Koczian Z, Nagy E. Characterization of the extended-spectrum β-lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary. J Antimicrob Chemother 1998; 42(3): 401-3.
24. Mulgrave L, Attwood PV. Characterization of an SHV-5 related extended-spectrum β-lactamase in Enterobacteriaceae from Western Australia. Pathology 1993; 25(1): 71-5.
25. Mulvey MR, Bryce B, Boyd D, et al. Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infection Surveillance Program, Health Canada. Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp in Canadian hospitals. Antimicrob Agents Chemother 2004; 48(4): 1204-14.
26. Miranda G, Castro N, Lcanos B, et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum β-lactamase in a Mexican pediatric hospital. J Clin Microbiol 2004; 42(1): 30-35.
27. Chanawong A, M'Zali F, Heritage J, Lulitanond A, Hawkey PM. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a University Hospital in Thailand. J Antimicrob Chemother 2001; 48(6): 839-52.
28. Paterson DL. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 2000; 6(9): 460-3.
29. Essack SY. Treatment options for extended-spectrum β-lactamase- producers. FEMS Microbiol Lett 2000; 190(2): 181-4.
30. Amyes SBG. Miles RS. Extended-spectrum β-lactamases: the role of inhibitors in therapy. J Antimicrob Chemother 1998; 42(4): 415-7.
31. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997; 41(3): 563-9.
32. MacKenzie FM, Forbes KJ, Dorai-John TM, Amyes SG. Emergence of carbapenem-resistant Klebsiella pneumoniae. Lancet 1997; 13, 350(9080): 783.